Teva Elects Dr. David J. Brailer to Board of Directors
TEVA PHARMACEUTICAL INDUSTRIES LTD
Subscribe to track TEVA
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) Item 5.02: Election of Director
• Appointee: Dr. David J. Brailer • Effective Date: November 3, 2026 • Committees: Human Resources and Compensation, Compliance • Independence: Independent under NYSE listing rules • Background: Former Chief Health Officer and Chief Transformation Officer of The Cigna Group; Founder & Executive Chairman of Health Evolution; previous board member at Walgreens Boots Alliance.
Comprehensive Analysis
Executive Summary
On October 27, 2026, the Board of Directors of Teva Pharmaceutical Industries Ltd. elected Dr. David J. Brailer to serve as an independent director, effective November 3, 2026, until Teva's 2027 annual general meeting of shareholders.
Key Appointment Details
- Role: Independent Director
- Effective Date: November 3, 2026
- Term: Until the 2027 Annual Meeting of Shareholders
- Committee Assignments: Expected to serve on the Human Resources and Compensation Committee and the Compliance Committee
- Compensation: Standard non-executive director compensation package as described in the Company's 2026 proxy statement
Appointee Background
- Current Roles: Chairman and CEO of medem.ai (since 2024), Founder and Executive Chairman of Health Evolution (since 2010), Vice Chairman of the Duke Margolis Health Policy Institute (since 2021).
- Past Roles: Chief Health Officer (2022–2026) and Chief Transformation Officer (2024–2026) at The Cigna Group.
- Prior Public Boards: Walgreens Boots Alliance, Inc. (2012–2021) and Prolacta Bioscience, Inc. (2012–2023).
- Education: Ph.D. in Management Science and Applied Economics from The Wharton School, M.D. from West Virginia University.
Governance & Compliance
- There are no related party transactions under Item 404(a) of Regulation S-K.
- There are no family relationships or third-party arrangements regarding Dr. Brailer's election.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.